About glp-1 medications
most healthcare providers believed that weight loss and obesity were simply due to a lack of willpower or maybe issues with the modern diet. that understanding was flipped on its head when researchers realized that GLP-1 receptor agonists could help patients lose weight without strict diet and exercise regimens.
it is now well established that patients are not "the problem," rather, patients are living with an illness that now has a treatment.
semaglutide*: this medication mimics the hormone GLP-1, which is naturally produced in the body. semaglutide is the active ingredient used in FDA-approved ozempic©, wegovy©, and rybelsus©. patients using FDA-approved versions of semaglutide often experience weight-loss of 15% of their body weight or more. on top of the incredible weight loss, these FDA-approved versions of semaglutide have been associated with improvements in blood sugar, heart health, and even longer life.
tirzepatide*: the newer, more effective cousin of semaglutide mimics two hormones, GLP-1 and GIP, which allows for greater weight loss and less side effects. tirzepatide is the active ingredient in FDA-approved mounjaro© and zepbound©. these FDA-approved versions of tirzepatide have been associated with weight loss of 25% or more of overall body weight. similar to semaglutide, FDA-approved versions of tirzepatide have also been associated with many other improvements in overall health.
GLP-1 medications, such as semaglutide and tirzepatide, mimic a natural hormone in your body that regulates appetite, blood sugar, and digestion. They help you feel fuller longer, reduce cravings, and support steady, sustainable weight loss.
Many individuals notice a reduced appetite within the first few weeks. Our goal is to promote healthy weight loss, approximately 1 to 2 lbs lost per week. Significant weight loss typically occurs over several months, with optimal results around the 6-12 month mark when combined with healthy eating and regular physical activity. Though these results have been shown through extensive clinical testing of name brand medications Wegovy and Zepbound, similar results have not been proven for compounded medications, although anecdotal evidence and clinical experience suggest results may be similar.
What about compounded GLP-1 medications?
Compounded semaglutide and tirzepatide may be an appropriate option for some patients. However, it is important to understand that compounded medications have not gone through clinical trials or testing for safety and efficacy and are not FDA-approved. There are additional risks involved when taking semaglutide or tirzepatide from sources other than branded, FDA-approved medications that you should discuss with your prescriber before using compounded medications. Compounded GLP-1 medications must not be confused with name brand medications like Ozempic, Wegovy, Rybelsus, Mounjaro, or Zepbound. They are not the same drugs. Only a licensed prescriber can determine if a compounded medication may benefit you.
Common side effects include mild nausea, bloating, or digestive changes, which often improve as your body adjusts. Staying hydrated, eating smaller meals, increasing protein intake, and following our guidance can help minimize discomfort.
Not necessarily. GLP-1 medications are tools to support long-term weight management. Some individuals continue using them, while others transition off with the help of lifestyle changes. We'll work with you to create a plan that aligns with your goals.
Do you prescribe Retatrutide?
Retatrutide is a peptide compound that is still undergoing research. Although it (along with a number of other research peptides) has shown promising results in preliminary clinical testing, it has not been approved for use in any drug by the FDA. Texas Obesity Medicine does not currently prescribe Retatrutide, but we are closely watching its development.
What are the costs of these medications?
Costs vary significantly depending on insurance coverage and medication prescribed. For instance, name brand, FDA-approved Wegovy can cost over $1000 per month if prescribed through a traditional pharmacy. On the other hand, the same FDA-approved medication, if prescribed through Novo Nordisk's newly established direct-to-consumer pharmacy program called NovoCare might only cost $499 per month. As another example, an individualized, non-FDA-approved compounded medication combining semaglutide and B-vitamins to help with gastrointestinal issues might only cost $99 per month, although it comes with the additional risks associated with compounded medications and can only be prescribed if medically-indicated. Finally, a non-GLP-1 medication, such as generic oral phentermine, may cost only $20 per month at a traditional pharmacy--or less if covered by insurance. As always, it is important you discuss options with your doctor, but note that cost is not a valid reason for a prescriber to prescribe compounded medications.
We're here to support you every step of the way. Don't hesitate to reach out!
We look forward to partnering with you on your journey to better health!
phone: 713-568-9102
fax: 713-900-2943
email: texasobesitymedicine@gmail.com
address: 5373 W Alabama St #204 Houston, TX 77056
*Compounded medications are not, and must not be confused with, brand name, FDA-approved medications. Texas Obesity Medicine, PLLC ("Texas Obesity Medicine") provides access to compounded medications for medically-qualified patients, as determined by a licensed prescriber. Texas Obesity Medicine is not a pharmacy and is not regulated under Sections 503A or 503B of the federal Food Drug and Cosmetics Act. Texas Obesity Medicine is a medical practice regulated under the laws, rules, and regulations of the state of Texas and the Texas Medical Board and only provides services to patients in the state of Texas. Texas Obesity Medicine prescribes medications as determined by a licensed provider following a review of medical history and patient presentation in an appropriate patient-provider encounter, whether virtual or in-person. Prescribers at Texas Obesity Medicine may, but are not required to or guaranteed to, prescribe compounded medications, if medically indicated. Compounded medications are not FDA-approved and there is a possibility that they may differ in risks, benefits, and side-effects from FDA-approved products. Individual results and experiences may vary. Novo Nordisk Inc. and Eli Lilly and Company are the only U.S. manufacturers of FDA-approved semaglutide (Rybelsus©, Ozempic©, Wegovy©) and tirzepatide (Zepbound©, Mounjaro©), respectively. These manufacturers do not sell these medications for compounding purposes. The Food and Drug Administration ("FDA") has stated that "[c]ompounded drugs . . . do not have the same safety, quality, and effectiveness assurances as approved drugs" and "[u]nnecessary use of compounded drugs unnecessarily exposes patients to potentially serious health risks." Only FDA-approved medications have been found to be safe and effective by the FDA. The FDA has stated that "[t]he safety and effectiveness of combining semaglutide with other ingredients," including B-vitamins, "has not been established." The safety and effectiveness of combining tirzepatide with other ingredients has likewise not been established by the FDA. GLP-1 medications compounded with B-vitamins do not offer any established enhanced weight loss benefits, and can only be prescribed by order of a licensed prescriber when medically indicated. Payment of a membership fee does not guarantee prescription of any medication, and your prescriber will determine what medication(s), including name brand, generic, and/or compounded medications, are indicated for your condition(s). If compounded medications are medically indicated as determined by a properly licensed prescriber, prescriptions will be sent to an appropriate facility in the state of Texas for fulfillment.
The information provided on this website is not a substitute for professional medical advice, diagnosis, or treatment and is provided for informational purposes only. If you have any concerns or questions about your health or any medical issue, please consult a physician or other appropriate, licensed medical professional. This website is an advertisement for professional services and not any specific medication. All listed prices are for illustrative purposes only and do not represent guarantees or commitments on the part of Texas Obesity Medicine or its providers that any medication is available or that said medication can be purchased at the listed prices, presently or in the future.
By accessing this website, you agree to accept the above statements and will not file or in any other way commence any civil action, complaint, petition, or other lawsuit regarding the above statements and disclaim any and all damages or claims for relief, in law or equity, as a result thereof.
Copyright Texas Obesity Medicine, PLLC, 2025. All rights reserved.